LSTA
Price
$2.17
Change
+$0.06 (+2.84%)
Updated
Sep 5 closing price
Capitalization
18.66M
61 days until earnings call
TPST
Price
$10.99
Change
+$0.96 (+9.57%)
Updated
Sep 5 closing price
Capitalization
48.8M
Interact to see
Advertisement

LSTA vs TPST

Header iconLSTA vs TPST Comparison
Open Charts LSTA vs TPSTBanner chart's image
Lisata Therapeutics
Price$2.17
Change+$0.06 (+2.84%)
Volume$12.13K
Capitalization18.66M
Tempest Therapeutics
Price$10.99
Change+$0.96 (+9.57%)
Volume$89.48K
Capitalization48.8M
LSTA vs TPST Comparison Chart in %
Loading...
LSTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TPST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LSTA vs. TPST commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSTA is a Hold and TPST is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (LSTA: $2.17 vs. TPST: $10.99)
Brand notoriety: LSTA and TPST are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LSTA: 28% vs. TPST: 106%
Market capitalization -- LSTA: $18.66M vs. TPST: $48.8M
LSTA [@Biotechnology] is valued at $18.66M. TPST’s [@Biotechnology] market capitalization is $48.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LSTA’s FA Score shows that 1 FA rating(s) are green whileTPST’s FA Score has 0 green FA rating(s).

  • LSTA’s FA Score: 1 green, 4 red.
  • TPST’s FA Score: 0 green, 5 red.
According to our system of comparison, TPST is a better buy in the long-term than LSTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LSTA’s TA Score shows that 3 TA indicator(s) are bullish while TPST’s TA Score has 5 bullish TA indicator(s).

  • LSTA’s TA Score: 3 bullish, 7 bearish.
  • TPST’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, TPST is a better buy in the short-term than LSTA.

Price Growth

LSTA (@Biotechnology) experienced а -6.47% price change this week, while TPST (@Biotechnology) price change was +10.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

LSTA is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TPST($48.8M) has a higher market cap than LSTA($18.7M). TPST YTD gains are higher at: 1.304 vs. LSTA (-27.181). LSTA has higher annual earnings (EBITDA): -20.83M vs. TPST (-42.04M). LSTA has more cash in the bank: 22M vs. TPST (14.3M). LSTA has less debt than TPST: LSTA (47K) vs TPST (8.66M). LSTA has higher revenues than TPST: LSTA (1.07M) vs TPST (0).
LSTATPSTLSTA / TPST
Capitalization18.7M48.8M38%
EBITDA-20.83M-42.04M50%
Gain YTD-27.1811.304-2,084%
P/E RatioN/AN/A-
Revenue1.07M0-
Total Cash22M14.3M154%
Total Debt47K8.66M1%
FUNDAMENTALS RATINGS
LSTA vs TPST: Fundamental Ratings
LSTA
TPST
OUTLOOK RATING
1..100
5125
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
53
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
8944
P/E GROWTH RATING
1..100
10089
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LSTA's Valuation (18) in the null industry is somewhat better than the same rating for TPST (53) in the Pharmaceuticals Major industry. This means that LSTA’s stock grew somewhat faster than TPST’s over the last 12 months.

LSTA's Profit vs Risk Rating (100) in the null industry is in the same range as TPST (100) in the Pharmaceuticals Major industry. This means that LSTA’s stock grew similarly to TPST’s over the last 12 months.

LSTA's SMR Rating (98) in the null industry is in the same range as TPST (100) in the Pharmaceuticals Major industry. This means that LSTA’s stock grew similarly to TPST’s over the last 12 months.

TPST's Price Growth Rating (44) in the Pharmaceuticals Major industry is somewhat better than the same rating for LSTA (89) in the null industry. This means that TPST’s stock grew somewhat faster than LSTA’s over the last 12 months.

TPST's P/E Growth Rating (89) in the Pharmaceuticals Major industry is in the same range as LSTA (100) in the null industry. This means that TPST’s stock grew similarly to LSTA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LSTATPST
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 15 days ago
80%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
LSTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TPST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DRTS3.600.11
+3.15%
Alpha Tau Medical Ltd
VECO24.510.63
+2.64%
Veeco Instruments
TCBS16.13N/A
N/A
Texas Community Bancshares
BMNR42.04-0.15
-0.36%
BitMine Immersion Technologies Inc.
WCPRF7.26-0.15
-2.02%
Whitecap Resources, Inc.

LSTA and

Correlation & Price change

A.I.dvisor tells us that LSTA and RAIN have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LSTA and RAIN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LSTA
1D Price
Change %
LSTA100%
+2.84%
RAIN - LSTA
27%
Poorly correlated
-3.30%
LGVN - LSTA
27%
Poorly correlated
+5.84%
ASND - LSTA
26%
Poorly correlated
+3.93%
CRIS - LSTA
26%
Poorly correlated
-1.75%
TPST - LSTA
26%
Poorly correlated
+9.57%
More

TPST and

Correlation & Price change

A.I.dvisor indicates that over the last year, TPST has been loosely correlated with PHIO. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TPST jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TPST
1D Price
Change %
TPST100%
+9.57%
PHIO - TPST
51%
Loosely correlated
-0.97%
ABCZF - TPST
49%
Loosely correlated
N/A
LXEO - TPST
41%
Loosely correlated
+1.01%
ARCT - TPST
39%
Loosely correlated
+6.50%
RXRX - TPST
38%
Loosely correlated
+1.99%
More